Bio-Path Holdings, Inc. (BPTH) vs Altamira Therapeutics Ltd. (CYTOF)
Bio-Path Holdings, Inc. and Altamira Therapeutics Ltd. are both Biotechnology companies. Bio-Path Holdings, Inc. and Altamira Therapeutics Ltd. are of similar size ($1.1M and $1.1M). Across the 8 metrics below, Bio-Path Holdings, Inc. leads on 6 and Altamira Therapeutics Ltd. on 2.
Valuation
Profitability
| Metric | BPTH | CYTOF | Biotechnology median |
|---|---|---|---|
| Gross margin | 0.00% | 0.00% | 65.16% |
| Operating margin | 0.00% | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% | 0.00% |
| Free cash flow margin | 0.00% | 0.00% | 0.00% |
| Return on equity | 157.01% | 0.00% | (57.72%) |
| Return on assets | (605.50%) | 0.00% | (49.22%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack